| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| None | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Basilea Pharmaceutica Ltd. (BSLN) | Cowen and Company/ Guggenheim Securities | $189.50 | N/C | |||
| EndoStim (STIM) | Wedbush PacGrow Life Sciences | 3.20 | $10.00 | $12.00 | $35.20 | n.a. |
| N/C = No Call – Stock traded on theSIX Swiss Exchange under the symbol “BSLN.” | ||||||
| n.a. (not available) | ||||||
| New Terms | ||||||
| Atlassian Corporation Plc (TEAM) | Goldman Sachs/ Morgan Stanley | 22.00 | $19.00 | $20.00 | $429.00 | 3-Stars |
| SoulCycle (SLCY) | Goldman Sachs/ BofA Merrill Lynch/ Citigroup | $100.00 | n.a. | |||
| Yirendai Ltd. (YRD) | Morgan Stanley/ Credit Suisse/ China Renaissance | 7.50 | $9.00 | $11.00 | $75.00 | 1-Star |
| n.a. (not available) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Dec. 7, 2015 | Manager(s) | Offered | Raised | Price | 12/11/15 | Change |
| Atlassian Corporation Plc (TEAM) | Goldman Sachs/ Morgan Stanley | 22.00 | $462.00 | $21.00 | $27.50 | 30.95% |
